Geode Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.25M Sell
2,377,694
-1,311,577
-36% -$1.24M ﹤0.01% 3105
2025
Q1
$1.7M Buy
3,689,271
+168,016
+5% +$77.4K ﹤0.01% 3104
2024
Q4
$2.6M Sell
3,521,255
-2,716
-0.1% -$2.01K ﹤0.01% 3037
2024
Q3
$5.53M Buy
3,523,971
+273,436
+8% +$429K ﹤0.01% 2707
2024
Q2
$5.46M Buy
3,250,535
+861,398
+36% +$1.45M ﹤0.01% 2675
2024
Q1
$5.73M Buy
2,389,137
+40,221
+2% +$96.5K ﹤0.01% 2624
2023
Q4
$3.59M Buy
2,348,916
+222,779
+10% +$341K ﹤0.01% 2863
2023
Q3
$2.32M Buy
2,126,137
+285,700
+16% +$311K ﹤0.01% 3025
2023
Q2
$4.21M Buy
1,840,437
+115,028
+7% +$263K ﹤0.01% 2781
2023
Q1
$4.19M Buy
1,725,409
+117,468
+7% +$285K ﹤0.01% 2718
2022
Q4
$3.07M Buy
1,607,941
+38,919
+2% +$74.3K ﹤0.01% 2892
2022
Q3
$3.77M Buy
1,569,022
+227,609
+17% +$546K ﹤0.01% 2821
2022
Q2
$2.5M Buy
1,341,413
+83,549
+7% +$155K ﹤0.01% 3037
2022
Q1
$2.63M Buy
1,257,864
+60,125
+5% +$126K ﹤0.01% 3115
2021
Q4
$4.72M Buy
1,197,739
+3,817
+0.3% +$15K ﹤0.01% 2927
2021
Q3
$5.74M Sell
1,193,922
-86,732
-7% -$417K ﹤0.01% 2831
2021
Q2
$5.88M Buy
1,280,654
+202,496
+19% +$929K ﹤0.01% 2807
2021
Q1
$6.33M Buy
1,078,158
+308,570
+40% +$1.81M ﹤0.01% 2668
2020
Q4
$2.63M Sell
769,588
-5,369
-0.7% -$18.4K ﹤0.01% 2929
2020
Q3
$1.12M Sell
774,957
-43,918
-5% -$63.2K ﹤0.01% 3168
2020
Q2
$1.63M Buy
818,875
+132,573
+19% +$264K ﹤0.01% 2950
2020
Q1
$1.34M Buy
686,302
+16,165
+2% +$31.5K ﹤0.01% 2889
2019
Q4
$2.78M Sell
670,137
-1,433
-0.2% -$5.95K ﹤0.01% 2796
2019
Q3
$2.02M Buy
671,570
+18,588
+3% +$55.9K ﹤0.01% 2936
2019
Q2
$4.11M Buy
652,982
+29,862
+5% +$188K ﹤0.01% 2516
2019
Q1
$3.46M Buy
623,120
+58,035
+10% +$323K ﹤0.01% 2538
2018
Q4
$3.75M Buy
565,085
+13,664
+2% +$90.7K ﹤0.01% 2398
2018
Q3
$5.88M Buy
551,421
+23,251
+4% +$248K ﹤0.01% 2248
2018
Q2
$6.34M Buy
528,170
+76,428
+17% +$917K ﹤0.01% 2177
2018
Q1
$3.87M Buy
451,742
+7,923
+2% +$67.9K ﹤0.01% 2403
2017
Q4
$4.38M Buy
443,819
+11,169
+3% +$110K ﹤0.01% 2283
2017
Q3
$5.32M Buy
432,650
+9,828
+2% +$121K ﹤0.01% 2172
2017
Q2
$6.96M Sell
422,822
-10,598
-2% -$174K ﹤0.01% 1909
2017
Q1
$6.22M Buy
433,420
+4,141
+1% +$59.4K ﹤0.01% 1957
2016
Q4
$5.94M Buy
429,279
+20,482
+5% +$283K ﹤0.01% 1951
2016
Q3
$7.39M Sell
408,797
-7,560
-2% -$137K ﹤0.01% 1694
2016
Q2
$5.97M Buy
416,357
+63,165
+18% +$906K ﹤0.01% 1793
2016
Q1
$4.22K Buy
353,192
+33,598
+11% +$401 ﹤0.01% 1973
2015
Q4
$4.25M Buy
319,594
+16,829
+6% +$224K ﹤0.01% 1983
2015
Q3
$3.25M Buy
302,765
+2,615
+0.9% +$28.1K ﹤0.01% 2128
2015
Q2
$2.42M Buy
300,150
+31,030
+12% +$250K ﹤0.01% 2378
2015
Q1
$1.78M Buy
269,120
+9,529
+4% +$63K ﹤0.01% 2517
2014
Q4
$1.65M Buy
259,591
+9,021
+4% +$57.4K ﹤0.01% 2541
2014
Q3
$2.47M Buy
250,570
+4,514
+2% +$44.6K ﹤0.01% 2234
2014
Q2
$2.77M Buy
246,056
+37
+0% +$417 ﹤0.01% 2178
2014
Q1
$2.98M Buy
246,019
+7,314
+3% +$88.6K ﹤0.01% 2102
2013
Q4
$3.01M Buy
238,705
+2,450
+1% +$30.9K ﹤0.01% 2057
2013
Q3
$3.92M Sell
236,255
-62,213
-21% -$1.03M ﹤0.01% 1740
2013
Q2
$4.53M Buy
+298,468
New +$4.53M ﹤0.01% 1488